Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
33K characters. Original on sec.gov ·
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
| --- | --- |
Statements in this Quarterly Report on Form
10-Q
which are not historical facts, so called “forward-looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form
10-Q
and Part I, Item 1A “Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2021. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are a leading global supplier of automation equipment for test and industrial applications. We design, develop, manufacture and sell automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our industrial automation products include collaborative robotic arms, autonomous mobile robots (“AMRs”) and advanced robotic control software used by global manufacturing, logistics and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Our automatic test equipment and industrial automation products and services include:
| • | semiconductor test (“Semiconductor Test”) systems; |
|---|
| • | storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
|---|
| • | wireless test (“Wireless Test”) systems; and |
|---|
| • | industrial automation (“Industrial Automation”) products. |
|---|
The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our test products both through direct sales and sales to the customers’ supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.
In 2022, we expect lower demand in the mobility segment of our Semiconductor Test business due to a slower technology transition in one of our largest
end-markets.
We expect this demand to accelerate in 2023 as a result of the expected ramp in 3 nanometer volume production. We also expect demand in the automotive segment to strengthen through 2022.
Our Industrial Automation segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms, Mobile Industrial Robots A/S (“MiR”), a leading maker of AMRs for industrial automation and AutoGuide, LLC (“AutoGuide”), a maker of high payload AMRs. The market for our Industrial Automation segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (SMEs) throughout the world.
We expect our UR and MiR businesses to continue to grow in 2022, while our AutoGuide business will focus on continuing to invest to scale and integrate high payload AMR solutions. Both our test and industrial automation businesses will continue to be impacted by supply constraints which will in turn impact our revenue and may, along with inflation, increase costs in 2022.
Our corporate strategy continues to focus on profitably gaining market share in our test businesses through the introduction of differentiated products that target expanding segments and accelerating growth through continued investment in our Industrial Automation businesses. We plan to execute on our strategy while balancing capital allocations between returning capital to our shareholders through stock repurchases and dividends and using capital for opportunistic acquisitions.
Impact of the
COVID-19
Pandemic on our Business
The novel coronavirus
(COVID-19)
pandemic resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines,
shelter-in-place
orders, vaccination and testing mandates, and business limitations and shutdowns. These measures have impacted our
day-to-day
operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. We are continuing to monitor the rapidly evolving situation regarding the
COVID-19
pandemic particularly in China and the availability and impact of vaccinations globally. However, we are unable to accurately predict the full
impact of
COVID-19,
which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges or new strains or variants of the virus in areas where we do business, the availability and use of vaccinations, any further government actions to contain the virus or treat its impact, continuing shutdowns in China, and how quickly and to what extent normal economic and operating conditions can resume.
Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of May 6, 2022, the date of issuance of this Quarterly Report on Form
10-Q.
Health and Safety
In response to the
COVID-19
pandemic, we have taken proactive, aggressive action to protect the health and safety of our employees, customers, contract manufacturers and suppliers and we have complied with all government orders around the globe. The spread of
COVID-19
has caused us to modify our business practices, including implementing social distancing protocols, suspending employee travel, requiring employees to work remotely and cancelling physical participation in meetings. We may take further actions as may be required or recommended by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers.
Operations
We believe the
COVID-19
pandemic, and the numerous measures implemented by authorities in response, has adversely impacted our results of operations, including by increasing costs, but we cannot accurately estimate the amount of the impact to our first quarter of 2022 financial results or to our future financial results. In addition, the pandemic has disrupted our contract manufacturers and suppliers, and has resulted in supply constraints and in short-term cost increases to meet customer demand. While the duration and severity of the pandemic may further impact our workforce and operations, as well as those of our customers, contract manufacturers and suppliers, we expect that our manufacturing facilities will remain operational, at sufficient capacity to support production demand. We are monitoring our operations closely in an effort to avoid any potential productivity loss caused by responses to the
COVID-19
pandemic.
Supply
We have experienced interruptions to our supply chain as a result of the
COVID-19
pandemic. Our suppliers have faced and may continue to face difficulties maintaining operations in light of
COVID-19
disruptions and government-ordered restrictions. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles caused by the pandemic. There is no assurance that these efforts will be successful. The
COVID-19
pandemic may continue to disrupt our ability to obtain components required to manufacture our products, adversely affecting our operations and in some instances resulting in higher costs and delays, both for obtaining components and shipping finished goods to customers.
Demand
The
COVID-19
pandemic has significantly increased economic uncertainty in our markets. Demand for our Test products in China and other countries was strong throughout 2021 and in the first quarter of 2022. The
COVID-19
pandemic could cause further economic disruption that could cause demand for our products to decline, which would adversely affect our business.
Liquidity
Although there is continued uncertainty related to the impact of the
COVID-19
pandemic on our future results, we believe our business model and our current cash reserves leave us well-positioned to manage our business through this crisis. We have a strong balance sheet as well as an operating model that we believe is capable of flexing up and down with extreme demand swings while still remaining profitable. Based on our analysis, we believe our existing balances of cash and cash equivalents and our currently anticipated operating cash flows will be sufficient to meet our working capital needs and other capital and liquidity requirements for the next twelve months. However, due to the uncertainty related to the future impact of the
COVID-19
pandemic, in order to bolster our liquidity position, on May 1, 2020 we entered into a credit agreement providing for a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, we amended the credit agreement to extend its maturity to December 10, 2026 as further described in Note H: “Debt.” As of May 6, 2022, we have not borrowed any funds under the credit facility.
We are continuing to monitor the evolving situation regarding the
COVID-19
pandemic, the availability of vaccinations where we do business and guidance from government authorities around the world. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As a result, given the uncertain nature of this situation, we are not able to accurately predict the full extent of the impact of
COVID-19
on our business, financial condition, results of operations, liquidity, or cash flows in the future.
Impact of Russia’s invasion of Ukraine on our Business
We currently do not expect a significant impact on our results of operations in the future due to Russia’s invasion of Ukraine, as we have minimal business in Russia and Ukraine, both directly and indirectly. However, following the invasion, the U.S. and other countries imposed significant sanctions against the Russian government and many Russian companies and individuals. Although Teradyne does not have significant operations in Russia, the sanctions could impact Teradyne’s business in other countries and could have a negative impact on the Company’s future revenue and supply chain, either of which could adversely affect Teradyne’s business and financial results.
See Part II—Item 1A, “Risk Factors,” included in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2021 for our risk factors regarding risks associated with both the
COVID-19
pandemic and international conflicts.
Critical Accounting Policies and Estimates
We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the three months ended April 3, 2022 to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2021, except as noted below.
Critical accounting estimates are complex and may require significant judgment by management. Changes to the underlying assumptions may have a material impact on our financial condition and results of operations. These estimates may change, as new events occur, and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.
Convertible Debt
We adopted Accounting Standards Update (“ASU”) ASU
2020-06
–
“Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,”
on January 1, 2022 using the modified retrospective method of adoption
.
Under ASU
2020-06,
we account for a convertible debt instrument as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Unsettled shares are recorded in current debt, and there is no recognition of a debt discount, which was previously amortized to interest expense. We use the
if-converted
method in the diluted EPS calculation for convertible instruments. As a result of adoption, we recorded an increase of $1.4 million to current debt for unsettled shares, an increase of $6.6 million to long-term debt for unamortized debt discount, and an increase to retained earnings of $92.8 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional
paid-in
capital was reduced by $99.3 million.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates under different assumptions or conditions.
SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| Percentage of revenues: | ||||||||
| Revenues: | ||||||||
| Products | 83 | % | 85 | % | ||||
| Services | 17 | 15 | ||||||
| Total revenues | 100 | 100 | ||||||
| Cost of revenues: | ||||||||
| Cost of products | 32 | 34 | ||||||
| Cost of services | 8 | 7 | ||||||
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) | 40 | 41 | ||||||
| Gross profit | 60 | 59 | ||||||
| Operating expenses: | ||||||||
| Selling and administrative | 19 | 17 | ||||||
| Engineering and development | 14 | 13 | ||||||
| Acquired intangible assets amortization | 1 | 1 | ||||||
| Restructuring and other | 2 | (1 | ) | |||||
| Total operating expenses | 36 | 29 | ||||||
| Income from operations | 25 | 30 | ||||||
| Non-operating (income) expense: | ||||||||
| Interest income | — | — | ||||||
| Interest expense | — | 1 | ||||||
| Other (income) expense, net | 1 | — | ||||||
| Income before income taxes | 24 | 29 | ||||||
| Income tax provision | 2 | 2 | ||||||
| Net income | 21 | % | 26 | % | ||||
Results of Operations
First Quarter 2022 Compared to First Quarter 2021
Revenues
Revenues by our reportable segments were as follows:
| April 3, 2022 | April 4, 2021 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Semiconductor Test | $ | 482.3 | $ | 528.1 | $ | (45.8 | ) | |||||
| System Test | 118.7 | 132.8 | (14.1 | ) | ||||||||
| Industrial Automation | 103.2 | 80.0 | 23.2 | |||||||||
| Wireless Test | 51.5 | 40.9 | 10.6 | |||||||||
| $ | 755.4 | $ | 781.7 | $ | (26.3 | ) | ||||||
The decrease in Semiconductor Test revenues of $45.8 million, or 8.7%, was driven primarily by lower tester sales in high performance compute processor and industrial applications and lower memory test sales of flash memory testers. The decrease in System Test revenues of $14.1 million, or 10.6%, was primarily due to lower sales in Storage Test of system level and hard disk drive testers, partially offset by greater sales in Defense/Aerospace and Production Board Test. The increase in Industrial Automation revenues of $23.2 million, or 29.0%, was driven primarily by higher demand for collaborative robotic arms and MiR’s autonomous mobile robots. The rise in Wireless Test revenues of $10.6 million, or 25.9%, was primarily due to increase in connectivity test products and higher demand in ultra-wide band wireless test.
Revenues by country as a percentage of total revenues were as follows (1):
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| China | 19 | % | 19 | % | ||||
| Taiwan | 18 | 33 | ||||||
| United States | 15 | 10 | ||||||
| Korea | 13 | 8 | ||||||
| Europe | 10 | 7 | ||||||
| Japan | 6 | 3 | ||||||
| Malaysia | 5 | 4 | ||||||
| Thailand | 5 | 7 | ||||||
| Singapore | 4 | 3 | ||||||
| Philippines | 2 | 4 | ||||||
| Rest of World | 3 | 2 | ||||||
| 100 | % | 100 | % | |||||
| (1) | Revenues attributable to a country are based on location of customer site. |
|---|
Gross Profit
Our gross profit was as follows:
| For the Three Months Ended | ||||||||||||
| April 3, 2022 | April 4, 2021 | Dollar/Point Change | ||||||||||
| (in millions) | ||||||||||||
| Gross profit | $ | 454.9 | $ | 461.6 | $ | (6.7 | ) | |||||
| Percent of total revenues | 60.2 | % | 59.1 | % | 1.1 |
Gross profit as a percent of revenue increased by 1.1 points, primarily due to product mix in Semiconductor Test.
Selling and Administrative
Selling and administrative expenses were as follows:
| For the Three Months Ended | ||||||||||||
| April 3, 2022 | April 4, 2021 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Selling and administrative | $ | 140.2 | $ | 129.8 | $ | 10.4 | ||||||
| Percent of total revenues | 18.6 | % | 16.6 | % |
The increase of $10.4 million in selling and administrative expenses was primarily due to higher spending in Industrial Automation and Semiconductor Test, partially offset by lower variable compensation.
Engineering and Development
Engineering and development expenses were as follows:
| For the Three Months Ended | ||||||||||||
| April 3, 2022 | April 4, 2021 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Engineering and development | $ | 108.1 | $ | 100.4 | $ | 7.7 | ||||||
| Percent of total revenues | 14.3 | % | 12.8 | % |
The increase of $7.7 million in engineering and development expenses was due to higher spending across all segments, partially offset by lower variable compensation.
Restructuring and Other
During the three months ended April 3, 2022, we recorded a charge of $14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, which was settled on March 25, 2022 for $26.7 million. Previously, in the three months ended December 31, 2021, we recorded a charge of $12.0 million related to this earn-out dispute.
During the three months ended April 4, 2021, we recorded a gain of $7.2 million for the decrease in the fair value of the AutoGuide contingent consideration liability.
Interest and Other
| For the Three Months Ended | ||||||||||||
| April 3, 2022 | April 4, 2021 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Interest income | $ | (0.7 | ) | $ | (0.8 | ) | $ | 0.1 | ||||
| Interest expense | 1.0 | 6.0 | (5.0 | ) | ||||||||
| Other (income) expense, net | 5.2 | 3.8 | 1.4 |
Interest expense decreased by $5.0 million primarily due to the January 1, 2022 adoption of ASU
2020-06
which eliminated the amortization of the debt discount which was $3.6 million in the three months ended April 4, 2021. Other (income) expense, net increased by $1.4 million primarily due to changes in unrealized gains/losses on equity securities, from a $1.4 million gain in 2021 to a $2.2 million loss in 2022, partially offset by lower losses on convertible debt early conversions.
Income (Loss) Before Income Taxes
| For the Three Months Ended | ||||||||||||
| April 3, 2022 | April 4, 2021 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Semiconductor Test | $ | 149.7 | $ | 176.4 | $ | (26.7 | ) | |||||
| System Test | 41.3 | 51.1 | (9.8 | ) | ||||||||
| Wireless Test | 18.6 | 9.6 | 9.0 | |||||||||
| Industrial Automation | (5.1 | ) | (13.0 | ) | 7.9 | |||||||
| Corporate and Eliminations (1) | (24.2 | ) | (0.1 | ) | (24.1 | ) | ||||||
| $ | 180.4 | $ | 224.0 | $ | (43.6 | ) | ||||||
| (1) | Included in Corporate and Eliminations are legal fees, contingent consideration adjustments, interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, acquisition related charges and compensation and for the three months ended April 4, 2021, loss on convertible debt conversions. |
|---|
The decrease in income before income taxes in Semiconductor Test was driven primarily by lower revenues in compute processor and industrial applications and lower memory test sales of flash memory testers. The decrease in income before income taxes in System Test was primarily due to lower sales in Storage Test of system level and hard disk drive testers, partially offset by greater sales in Defense/Aerospace and Production Board Test. The elevated income before taxes in Industrial Automation was driven primarily by higher demand for collaborative robotic arms and MiR’s autonomous mobile robots. The rise in income before taxes in Wireless Test was driven primarily by an increase in connectivity test products and higher demand in ultra-wide band wireless test. The loss before income taxes in Corporate and Eliminations was primarily due to legal settlement charges related to litigation for the
earn-out
dispute in connection with the AutoGuide acquisition.
Income Taxes
The effective tax rate for the three months ended April 3, 2022 and April 4, 2021 was 10.2% and 8.3%, respectively. The increase in the effective tax rate from the three months ended April 4, 2021 to the three months ended April 3, 2022 was primarily attributable to a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions, and an increase in
non-deductible
officers’ compensation. These increases in expense were partially offset by an increase in benefit from equity compensation.
Contractual Obligations
There have been no changes outside of the ordinary course of business to our contractual obligations as disclosed in our Annual Report on Form
10-K
for the year ended December 31, 2021.
Liquidity and Capital Resources
Our cash, cash equivalents, and marketable securities balances decreased by $297.5 million in the three months ended April 3, 2022 to $1,202.7 million.
Operating activities during the three months ended April 3, 2022 provided cash of $7.5 million. Changes in operating assets and liabilities used cash of $210.2 million. This was due to an $83.6 million increase in operating assets and a $126.6 million decrease in operating liabilities.
The increase in operating assets was due to a $74.3 million increase in prepayments and other assets due to prepayments to our contract manufacturers, a $9.5 million increase in inventories, partially offset by a $0.2 million decrease in accounts receivable.
The decrease in operating liabilities was due to a $114.0 million decrease in accrued employee compensation, a $13.8 million decrease in other accrued liabilities, a $7.6 million decrease in income taxes, and $1.3 million of retirement plan contributions, partially offset by a $6.7 million increase in deferred revenue and customer advance payments, and a $3.4 million increase in accounts payable.
Investing activities during the three months ended April 3, 2022 used cash of $82.7 million due to $166.0 million used for purchases of marketable securities, and $44.0 million used for purchases of property, plant and equipment, partially offset by $96.7 million and $30.6 million in proceeds from maturities and sales of marketable securities, respectively.
Financing activities during the three months ended April 3, 2022 used cash of $254.6 million due to $201.5 million used for the repurchase of 1.8 million shares of common stock at an average price of $115.12 per share, $31.0 million used for payment related to net settlements of employee stock compensation awards, $20.7 million used for payments of convertible debt principal, $17.9 million used for dividend payments, partially offset by $16.5 million from the issuance of common stock under employee stock purchase and stock option plans.
Operating activities during the three months ended April 4, 2021 provided cash of $38.1 million. Changes in operating assets and liabilities used cash of $209.1 million. This was due to a $209.5 million increase in operating assets and a $0.4 million increase in operating liabilities.
The increase in operating assets was due to an $87.5 million greater accounts receivable due to improved sales, an $86.1 million increase in prepayments and other assets due to prepayments to our contract manufacturers as a result of higher forecasted revenues, and a $35.9 million rise in inventories.
The change in operating liabilities was due to a $44.5 million rise in accounts payable, a $26.4 million increase in other accrued liabilities, an $8.0 million increase in deferred revenue and customer advance payments, and a $4.9 million increase in income taxes, partially offset by an $81.5 million decrease in accrued employee compensation and $1.9 million of retirement plan contributions.
Investing activities during the three months ended April 4, 2021 provided cash of $4.7 million due to $194.2 million and $61.3 million in proceeds from maturities and sales of marketable securities, respectively, partially offset by $211.6 million used for purchases of marketable securities, and $39.3 million used for purchases of property, plant and equipment.
Financing activities during the three months ended April 4, 2021 used cash of $126.7 million, due to $51.3 million used for payments of convertible debt principal, $45.2 million used for the repurchase of 0.4 million shares of common stock at an average price of $120.73 per share, $30.7 million used for payments related to net settlements of employee stock compensation awards, and $16.7 million used for dividend payments, partially offset by $17.1 million from the issuance of common stock under employee stock purchase and stock option plans.
In January 2022, Teradyne’s Board of Directors declared a 10% increase in the quarterly cash dividend to $0.11 per share. Dividend payments for the three months ended April 3, 2022 were $17.9 million. In January 2021, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended April 4, 2021 were $16.7 million.
In January 2021, our Board of Directors approved a new repurchase program for up to $2.0 billion of common stock. Unless terminated by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the share repurchase program. We intend to repurchase a minimum of $750.0 million in 2022.
During the three months ended April 3, 2022, we repurchased 1.8 million shares of common stock for $201.5 million at an average price of $115.12 per share. During the three months ended April 4, 2021, we repurchased 0.4 million shares of common stock for $45.2 million at an average price of $120.73 per share.
While we declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.
On May 1, 2020, we entered into a credit agreement providing a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, the credit agreement was amended to extend the senior secured revolving credit facility to December 10, 2026. As of May 6, 2022, we have not borrowed any funds under the credit facility.
We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the
COVID-19
pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.
Equity Compensation Plans
As discussed in Note Q: “Stock-Based Compensation” in our 2021 Annual Report on Form
10-K,
we have a 1996 Employee Stock Purchase Plan and a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).
The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers, directors, consultants and/or advisors. Both plans were approved by our shareholders.
Recently Issued Accounting Pronouncements
For the three months ended April 3, 2022, there were no recently issued accounting pronouncements that had, or are expected to have, a material impact to our consolidated financial statements.
Previous: Item 1. Financial Statements · Next: Item 3. Quantitative and Qualitative Disclosures about Market Risks